Last reviewed · How we verify
XRX-001 Inactivated yellow fever vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
XRX-001 Inactivated yellow fever vaccine (XRX-001 Inactivated yellow fever vaccine) — GE Healthcare.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| XRX-001 Inactivated yellow fever vaccine TARGET | XRX-001 Inactivated yellow fever vaccine | GE Healthcare | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- XRX-001 Inactivated yellow fever vaccine CI watch — RSS
- XRX-001 Inactivated yellow fever vaccine CI watch — Atom
- XRX-001 Inactivated yellow fever vaccine CI watch — JSON
- XRX-001 Inactivated yellow fever vaccine alone — RSS
Cite this brief
Drug Landscape (2026). XRX-001 Inactivated yellow fever vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/xrx-001-inactivated-yellow-fever-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab